Position in INVA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$91,669,641
-$2,826,584 QoQ
Shares Held
4,036,532
-0.5% QoQ
Ownership
5.59%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#4
of 307 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. INVA ranks #10 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in INVA
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $91,669,641 | 4,036,532 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $94,496,225 | 4,055,632 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $84,161,338 | 4,210,172 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $83,711,509 | 4,586,932 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $95,645,114 | 4,760,832 | Shares | Sole | 2025-08-13 | |
| 2025-04-01 | $85,409,326 | 4,760,832 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $82,622,616 | 4,557,232 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $73,941,050 | 4,261,732 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $83,610,504 | 4,329,907 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $70,944,874 | 4,325,907 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $66,528,802 | 4,365,407 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $66,476,929 | 4,144,447 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $51,952,296 | 3,999,407 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $48,995,822 | 3,848,847 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $44,101,653 | 3,920,147 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $56,042,292 | 4,229,607 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $49,524,463 | 4,265,673 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $70,832,841 | 4,798,973 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $100,883,798 | 5,213,633 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $91,341,044 | 5,295,133 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $90,976,625 | 5,444,442 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $78,816,497 | 5,877,442 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $90,612,571 | 7,582,642 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $97,655,526 | 7,881,802 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $87,723,684 | 8,394,611 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $119,260,737 | 8,530,811 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $96,479,169 | 8,204,011 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||